Recall record at a glance
| Official record | F-2138-2016 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | Gasco Industrial |
| Report date | Sep 21, 2016 |
| Recall initiation date | Jun 15, 2016 |
| Quantity | 3079 units |
| Location | Gurabo, PR, United States |
Official product description
Label reads in part as: "Gasc QUALITY BRAND***Salsa Soya (Soy Sauce)***Contenido Neto (Net Content): 1 Gal¿n (1 Gallon) (3.79 L)***GASCO INDUSTRIAL CORP. P.O. BOX 1360 GURABO, P.R. 00778 TEL. (787) 737-4000".
Why the product was recalled
Undeclared wheat in the soy sauce products. Recall started on 6/15/16.
Distribution information
Puerto Rico and Saint Berthelemy
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.